Empowered Funds LLC Purchases New Shares in Cabot Corporation $CBT

Empowered Funds LLC purchased a new position in Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 34,651 shares of the specialty chemicals company’s stock, valued at approximately $3,147,000.

Other institutional investors have also added to or reduced their stakes in the company. Public Employees Retirement System of Ohio lifted its position in Cabot by 15.4% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock valued at $80,000 after buying an additional 160 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Cabot by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after acquiring an additional 161 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of Cabot by 10.5% in the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock worth $139,000 after acquiring an additional 175 shares in the last quarter. Swiss Life Asset Management Ltd lifted its position in Cabot by 3.6% during the 2nd quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company’s stock valued at $558,000 after acquiring an additional 212 shares during the period. Finally, Rothschild Investment LLC lifted its position in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 259 shares during the period. Institutional investors own 93.18% of the company’s stock.

Wall Street Analysts Forecast Growth

CBT has been the topic of several research reports. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. UBS Group decreased their target price on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Finally, Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $89.00.

Insider Activity

In other news, CEO Sean D. Keohane sold 134,895 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the sale, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders have sold a total of 229,597 shares of company stock valued at $19,646,746 in the last 90 days. Corporate insiders own 3.08% of the company’s stock.

Cabot Price Performance

CBT opened at $80.56 on Wednesday. The stock has a 50-day moving average price of $87.32 and a 200-day moving average price of $81.32. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The firm has a market cap of $4.16 billion, a PE ratio of 22.69, a P/E/G ratio of 10.86 and a beta of 0.84. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. Cabot’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is currently 53.24%.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.